This inventor holds 1 USPTO granted patent. Top assignees: Asieris Pharmaceuticals (Shanghai) Co., Ltd., Jiangsu Yahong Meditech Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jie Chen - Innovator in Pharmaceutical Compositions
Introduction
Jie Chen is a notable inventor based in Taizhou, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent related to pharmaceutical compositions.
Latest Patents
Jie Chen holds a patent for "Pharmaceutical compositions comprising nitroxoline lysinate, preparation method therefor and use thereof." This invention involves pharmaceutical compositions that consist of a first layer and a second layer. The first layer includes 40%-70% of an active pharmaceutical ingredient, 10%-30% of filler, 5%-12% of disintegrant, 0.5%-2% of lubricant, 0.1%-1.5% of glidant, and 10%-20% of an alkaline substance. The second layer comprises 40%-70% of the active pharmaceutical ingredient, 10%-30% of filler, 10%-35% of sustained-release material, 0.1%-2% of lubricant, and 0.1%-2% of glidant. The active pharmaceutical ingredient can be selected from nitroxoline lysinate, its crystalline form, or its solvate. This innovative composition allows for burst release at an early stage and sustained, slow release at a later stage.
Career Highlights
Throughout his career, Jie Chen has worked with prominent companies in the pharmaceutical industry, including Jiangsu Yahong Meditech Co., Ltd. and Asieris Pharmaceuticals (Shanghai) Co., Ltd. His work has contributed to advancements in drug formulation and delivery systems.
Collaborations
Jie Chen has collaborated with notable colleagues such as Jianghua Liu and Ke Pan. Their combined expertise has furthered the development of innovative pharmaceutical solutions.
Conclusion
Jie Chen's contributions to pharmaceutical compositions demonstrate his commitment to innovation in the field. His patent reflects a significant advancement in drug delivery systems, showcasing his role as a key inventor in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile